The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dexlansoprazole Market Research Report 2024
Synopsis
Dexlansoprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach. Dexlansoprazole is used to treat heartburn caused by gastroesophageal reflux disease (GERD), and to heal erosive esophagitis (damage to the esophagus from stomach acid).
The global Dexlansoprazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dexlansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dexlansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dexlansoprazole include Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical and Sailong, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dexlansoprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dexlansoprazole.
Report Scope
The Dexlansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dexlansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dexlansoprazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Cardinal Health
Suzhou Homesun Pharmaceutical
Frontida
Zhendong Group
Ouya Pharmaceutical
Heron Pharmaceutical
Sailong
Segment by Type
30 mg
60 mg
Segment by Application
Gastroesophageal Reflux Disease
Heal Erosive Esophagitis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dexlansoprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dexlansoprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Dexlansoprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach. Dexlansoprazole is used to treat heartburn caused by gastroesophageal reflux disease (GERD), and to heal erosive esophagitis (damage to the esophagus from stomach acid).
The global Dexlansoprazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dexlansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dexlansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dexlansoprazole include Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical and Sailong, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dexlansoprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dexlansoprazole.
Report Scope
The Dexlansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dexlansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dexlansoprazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Cardinal Health
Suzhou Homesun Pharmaceutical
Frontida
Zhendong Group
Ouya Pharmaceutical
Heron Pharmaceutical
Sailong
Segment by Type
30 mg
60 mg
Segment by Application
Gastroesophageal Reflux Disease
Heal Erosive Esophagitis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dexlansoprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dexlansoprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Dexlansoprazole Market Overview
1.1 Product Overview and Scope of Dexlansoprazole
1.2 Dexlansoprazole Segment by Type
1.2.1 Global Dexlansoprazole Market Value Comparison by Type (2024-2030)
1.2.2 30 mg
1.2.3 60 mg
1.3 Dexlansoprazole Segment by Application
1.3.1 Global Dexlansoprazole Market Value by Application: (2024-2030)
1.3.2 Gastroesophageal Reflux Disease
1.3.3 Heal Erosive Esophagitis
1.4 Global Dexlansoprazole Market Size Estimates and Forecasts
1.4.1 Global Dexlansoprazole Revenue 2019-2030
1.4.2 Global Dexlansoprazole Sales 2019-2030
1.4.3 Global Dexlansoprazole Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dexlansoprazole Market Competition by Manufacturers
2.1 Global Dexlansoprazole Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dexlansoprazole Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dexlansoprazole Average Price by Manufacturers (2019-2024)
2.4 Global Dexlansoprazole Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dexlansoprazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dexlansoprazole, Product Type & Application
2.7 Dexlansoprazole Market Competitive Situation and Trends
2.7.1 Dexlansoprazole Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dexlansoprazole Players Market Share by Revenue
2.7.3 Global Dexlansoprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dexlansoprazole Retrospective Market Scenario by Region
3.1 Global Dexlansoprazole Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dexlansoprazole Global Dexlansoprazole Sales by Region: 2019-2030
3.2.1 Global Dexlansoprazole Sales by Region: 2019-2024
3.2.2 Global Dexlansoprazole Sales by Region: 2025-2030
3.3 Global Dexlansoprazole Global Dexlansoprazole Revenue by Region: 2019-2030
3.3.1 Global Dexlansoprazole Revenue by Region: 2019-2024
3.3.2 Global Dexlansoprazole Revenue by Region: 2025-2030
3.4 North America Dexlansoprazole Market Facts & Figures by Country
3.4.1 North America Dexlansoprazole Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dexlansoprazole Sales by Country (2019-2030)
3.4.3 North America Dexlansoprazole Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dexlansoprazole Market Facts & Figures by Country
3.5.1 Europe Dexlansoprazole Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dexlansoprazole Sales by Country (2019-2030)
3.5.3 Europe Dexlansoprazole Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dexlansoprazole Market Facts & Figures by Country
3.6.1 Asia Pacific Dexlansoprazole Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dexlansoprazole Sales by Country (2019-2030)
3.6.3 Asia Pacific Dexlansoprazole Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dexlansoprazole Market Facts & Figures by Country
3.7.1 Latin America Dexlansoprazole Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dexlansoprazole Sales by Country (2019-2030)
3.7.3 Latin America Dexlansoprazole Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dexlansoprazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Dexlansoprazole Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dexlansoprazole Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dexlansoprazole Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dexlansoprazole Sales by Type (2019-2030)
4.1.1 Global Dexlansoprazole Sales by Type (2019-2024)
4.1.2 Global Dexlansoprazole Sales by Type (2025-2030)
4.1.3 Global Dexlansoprazole Sales Market Share by Type (2019-2030)
4.2 Global Dexlansoprazole Revenue by Type (2019-2030)
4.2.1 Global Dexlansoprazole Revenue by Type (2019-2024)
4.2.2 Global Dexlansoprazole Revenue by Type (2025-2030)
4.2.3 Global Dexlansoprazole Revenue Market Share by Type (2019-2030)
4.3 Global Dexlansoprazole Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dexlansoprazole Sales by Application (2019-2030)
5.1.1 Global Dexlansoprazole Sales by Application (2019-2024)
5.1.2 Global Dexlansoprazole Sales by Application (2025-2030)
5.1.3 Global Dexlansoprazole Sales Market Share by Application (2019-2030)
5.2 Global Dexlansoprazole Revenue by Application (2019-2030)
5.2.1 Global Dexlansoprazole Revenue by Application (2019-2024)
5.2.2 Global Dexlansoprazole Revenue by Application (2025-2030)
5.2.3 Global Dexlansoprazole Revenue Market Share by Application (2019-2030)
5.3 Global Dexlansoprazole Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Dexlansoprazole Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Cardinal Health
6.2.1 Cardinal Health Corporation Information
6.2.2 Cardinal Health Description and Business Overview
6.2.3 Cardinal Health Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cardinal Health Dexlansoprazole Product Portfolio
6.2.5 Cardinal Health Recent Developments/Updates
6.3 Suzhou Homesun Pharmaceutical
6.3.1 Suzhou Homesun Pharmaceutical Corporation Information
6.3.2 Suzhou Homesun Pharmaceutical Description and Business Overview
6.3.3 Suzhou Homesun Pharmaceutical Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Suzhou Homesun Pharmaceutical Dexlansoprazole Product Portfolio
6.3.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
6.4 Frontida
6.4.1 Frontida Corporation Information
6.4.2 Frontida Description and Business Overview
6.4.3 Frontida Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Frontida Dexlansoprazole Product Portfolio
6.4.5 Frontida Recent Developments/Updates
6.5 Zhendong Group
6.5.1 Zhendong Group Corporation Information
6.5.2 Zhendong Group Description and Business Overview
6.5.3 Zhendong Group Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhendong Group Dexlansoprazole Product Portfolio
6.5.5 Zhendong Group Recent Developments/Updates
6.6 Ouya Pharmaceutical
6.6.1 Ouya Pharmaceutical Corporation Information
6.6.2 Ouya Pharmaceutical Description and Business Overview
6.6.3 Ouya Pharmaceutical Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ouya Pharmaceutical Dexlansoprazole Product Portfolio
6.6.5 Ouya Pharmaceutical Recent Developments/Updates
6.7 Heron Pharmaceutical
6.6.1 Heron Pharmaceutical Corporation Information
6.6.2 Heron Pharmaceutical Description and Business Overview
6.6.3 Heron Pharmaceutical Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Heron Pharmaceutical Dexlansoprazole Product Portfolio
6.7.5 Heron Pharmaceutical Recent Developments/Updates
6.8 Sailong
6.8.1 Sailong Corporation Information
6.8.2 Sailong Description and Business Overview
6.8.3 Sailong Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sailong Dexlansoprazole Product Portfolio
6.8.5 Sailong Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dexlansoprazole Industry Chain Analysis
7.2 Dexlansoprazole Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dexlansoprazole Production Mode & Process
7.4 Dexlansoprazole Sales and Marketing
7.4.1 Dexlansoprazole Sales Channels
7.4.2 Dexlansoprazole Distributors
7.5 Dexlansoprazole Customers
8 Dexlansoprazole Market Dynamics
8.1 Dexlansoprazole Industry Trends
8.2 Dexlansoprazole Market Drivers
8.3 Dexlansoprazole Market Challenges
8.4 Dexlansoprazole Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
